Suppr超能文献

CASQ1基因的突变会导致一种伴有肌浆网蛋白聚集体积累的空泡性肌病。

A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.

作者信息

Rossi Daniela, Vezzani Bianca, Galli Lucia, Paolini Cecilia, Toniolo Luana, Pierantozzi Enrico, Spinozzi Simone, Barone Virginia, Pegoraro Elena, Bello Luca, Cenacchi Giovanna, Vattemi Gaetano, Tomelleri Giuliano, Ricci Giulia, Siciliano Gabriele, Protasi Feliciano, Reggiani Carlo, Sorrentino Vincenzo

机构信息

Molecular Medicine Section, Department of Molecular and Developmental Medicine, University of Siena and Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy; IIM, Interuniversity Institute of Myology.

出版信息

Hum Mutat. 2014 Oct;35(10):1163-70. doi: 10.1002/humu.22631. Epub 2014 Sep 10.

Abstract

A missense mutation in the calsequestrin-1 gene (CASQ1) was found in a group of patients with a myopathy characterized by weakness, fatigue, and the presence of large vacuoles containing characteristic inclusions resulting from the aggregation of sarcoplasmic reticulum (SR) proteins. The mutation affects a conserved aspartic acid in position 244 (p.Asp244Gly) located in one of the high-affinity Ca(2+) -binding sites of CASQ1 and alters the kinetics of Ca(2+) release in muscle fibers. Expression of the mutated CASQ1 protein in COS-7 cells showed a markedly reduced ability in forming elongated polymers, whereas both in cultured myotubes and in in vivo mouse fibers induced the formation of electron-dense SR vacuoles containing aggregates of the mutant CASQ1 protein that resemble those observed in muscle biopsies of patients. Altogether, these results support the view that a single missense mutation in the CASQ1 gene causes the formation of abnormal SR vacuoles containing aggregates of CASQ1, and other SR proteins, results in altered Ca(2+) release in skeletal muscle fibers, and, hence, is responsible for the clinical phenotype observed in these patients.

摘要

在一组患有肌病的患者中发现了钙结合蛋白-1基因(CASQ1)的错义突变。该肌病的特征为肌无力、疲劳,以及存在含有由肌浆网(SR)蛋白聚集形成的特征性内含物的大液泡。该突变影响位于CASQ1的一个高亲和力Ca(2+)结合位点中的第244位保守天冬氨酸(p.Asp244Gly),并改变了肌纤维中Ca(2+)释放的动力学。突变的CASQ1蛋白在COS-7细胞中的表达显示形成细长聚合物的能力明显降低,而在培养的肌管和体内小鼠纤维中均诱导形成了含有突变CASQ1蛋白聚集体的电子致密SR液泡,这些聚集体类似于在患者肌肉活检中观察到的聚集体。总之,这些结果支持以下观点:CASQ1基因中的单个错义突变导致形成含有CASQ1和其他SR蛋白聚集体的异常SR液泡,导致骨骼肌纤维中Ca(2+)释放改变,因此,是这些患者中观察到的临床表型的原因。

相似文献

2
A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.
PLoS One. 2016 May 19;11(5):e0155516. doi: 10.1371/journal.pone.0155516. eCollection 2016.
3
Pathological mechanisms of vacuolar aggregate myopathy arising from a Casq1 mutation.
FASEB J. 2021 May;35(5):e21349. doi: 10.1096/fj.202001653RR.
4
The clinical spectrum of -related myopathy.
Neurology. 2018 Oct 23;91(17):e1629-e1641. doi: 10.1212/WNL.0000000000006387. Epub 2018 Sep 26.
5
A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia.
J Med Genet. 2015 Sep;52(9):617-26. doi: 10.1136/jmedgenet-2014-102882. Epub 2015 Jul 1.
6
Calsequestrin (CASQ1) rescues function and structure of calcium release units in skeletal muscles of CASQ1-null mice.
Am J Physiol Cell Physiol. 2012 Feb 1;302(3):C575-86. doi: 10.1152/ajpcell.00119.2011. Epub 2011 Nov 2.
8
Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.
J Muscle Res Cell Motil. 2011 Dec;32(4-5):257-70. doi: 10.1007/s10974-011-9277-2. Epub 2011 Dec 1.
9
Characterization of Two Human Skeletal Calsequestrin Mutants Implicated in Malignant Hyperthermia and Vacuolar Aggregate Myopathy.
J Biol Chem. 2015 Nov 27;290(48):28665-74. doi: 10.1074/jbc.M115.686261. Epub 2015 Sep 28.
10
Mice null for calsequestrin 1 exhibit deficits in functional performance and sarcoplasmic reticulum calcium handling.
PLoS One. 2011;6(12):e27036. doi: 10.1371/journal.pone.0027036. Epub 2011 Dec 2.

引用本文的文献

2
Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches.
Dis Model Mech. 2024 Oct 1;17(10). doi: 10.1242/dmm.050720. Epub 2024 Nov 6.
3
: Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy.
Cells. 2024 Sep 8;13(17):1504. doi: 10.3390/cells13171504.
4
TAM-associated CASQ1 mutants diminish intracellular Ca content and interfere with regulation of SOCE.
J Muscle Res Cell Motil. 2024 Dec;45(4):275-284. doi: 10.1007/s10974-024-09681-9. Epub 2024 Aug 10.
6
Physiology of intracellular calcium buffering.
Physiol Rev. 2023 Oct 1;103(4):2767-2845. doi: 10.1152/physrev.00042.2022. Epub 2023 Jun 16.
7
CASQ1-related myopathy: The first report from China and the literature review.
Clin Case Rep. 2022 Dec 8;10(12):e6689. doi: 10.1002/ccr3.6689. eCollection 2022 Dec.
8
Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy.
Eur J Neurosci. 2022 Aug;56(3):4214-4223. doi: 10.1111/ejn.15728. Epub 2022 Jun 13.
9
The Sarcoplasmic Reticulum of Skeletal Muscle Cells: A Labyrinth of Membrane Contact Sites.
Biomolecules. 2022 Mar 23;12(4):488. doi: 10.3390/biom12040488.
10
Critical role of Znhit1 for postnatal heart function and vacuolar cardiomyopathy.
JCI Insight. 2022 Mar 22;7(6):e148752. doi: 10.1172/jci.insight.148752.

本文引用的文献

2
Identification of calcium binding sites on calsequestrin 1 and their implications for polymerization.
Mol Biosyst. 2013 Jul;9(7):1949-57. doi: 10.1039/c3mb25588c. Epub 2013 Apr 29.
3
CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.
Anesthesiology. 2013 Feb;118(2):344-9. doi: 10.1097/01.anes.0000530185.78660.da.
4
Protein aggregate myopathies: the many faces of an expanding disease group.
Acta Neuropathol. 2013 Jan;125(1):1-2. doi: 10.1007/s00401-012-1071-8.
5
Molecular mechanisms of pharmaceutical drug binding into calsequestrin.
Int J Mol Sci. 2012 Nov 6;13(11):14326-43. doi: 10.3390/ijms131114326.
6
High-capacity Ca2+ binding of human skeletal calsequestrin.
J Biol Chem. 2012 Mar 30;287(14):11592-601. doi: 10.1074/jbc.M111.335075. Epub 2012 Feb 15.
7
Protein aggregation in congenital myopathies.
Semin Pediatr Neurol. 2011 Dec;18(4):272-6. doi: 10.1016/j.spen.2011.10.009.
8
Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.
J Muscle Res Cell Motil. 2011 Dec;32(4-5):257-70. doi: 10.1007/s10974-011-9277-2. Epub 2011 Dec 1.
9
Calsequestrin (CASQ1) rescues function and structure of calcium release units in skeletal muscles of CASQ1-null mice.
Am J Physiol Cell Physiol. 2012 Feb 1;302(3):C575-86. doi: 10.1152/ajpcell.00119.2011. Epub 2011 Nov 2.
10
Fiber types in mammalian skeletal muscles.
Physiol Rev. 2011 Oct;91(4):1447-531. doi: 10.1152/physrev.00031.2010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验